Pharmaceutical Published Insights

Published Date : 30 Apr, 2026

The H2 receptor antagonist Market is estimated to be valued at USD 4.77 Bn in 2026 and is expected to reach USD 7.41 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033. H2 receptor antagonists... View more

Published Date : 30 Apr, 2026

Medicinal mushrooms have been utilized for centuries as traditional remedies and tonics across various Eastern cultures. These mushrooms are now gaining popularity worldwide due to their purported health benefits and immunomodulatory properties. Key medicinal mushroom... View more

Published Date : 30 Apr, 2026

Skin rashes affect people of all age groups and can occur due to various reasons such as allergies, infections, change in climate etc. Skin rashes cause severe itching, redness and inflammation on the skin. The skin rash treatment market offers a wide range of product... View more

Published Date : 30 Apr, 2026

Complex chronic conditions refer to multiple chronic conditions occurring simultaneously in a person. These include conditions like diabetes, cancer, arthritis, COPD, Alzheimer's, and others. Factors such as rising geriatric population, increasing incidence of chronic... View more

Published Date : 30 Apr, 2026

The incretin mimetics market is estimated to be valued at USD 25.08 Bn in 2026 and is expected to reach USD 35.76 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.2% from 2026 to 2033. Incretin mimetics are a cl... View more

Published Date : 30 Apr, 2026

The antihistamine drugs market is estimated to be valued at USD 109.47 Bn in 2026 and is expected to reach USD 182.81 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033. Antihistamine drugs are a ... View more

Published Date : 30 Apr, 2026

The ethical pharmaceuticals market is estimated to be valued at USD 5.82 Bn in 2026 and is expected to reach USD 11.86 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.7% from 2026 to 2033. The ethical pharmace... View more

Published Date : 30 Apr, 2026

The paclitaxel injection market is estimated to be valued at USD 8.07 Bn in 2026 and is expected to reach USD 18.87 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.9% from 2026 to 2033. The paclitaxel injectio... View more

Published Date : 30 Apr, 2026

The global Sever's Disease Treatment Market is estimated to be valued at USD 1.48 Bn in 2026 and is expected to reach USD 2.13 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2033. Sever's disease, ... View more

Published Date : 30 Apr, 2026

The global uterine fibroids treatment drugs market is estimated to be valued at USD 2.19 Bn in 2026 and is expected to exhibit a CAGR of 8.3% during the forecast period (2026 - 2033). Uterine fibroids are non-cancerous tumors that grow in or on a woman's uterus. Sym... View more

Published Date : 30 Apr, 2026

Artificial intelligence (AI) has emerged as a transformative technology that is poised to revolutionize the pharmaceutical industry. By leveraging huge amounts of data and sophisticated algorithms, AI has the potential to help drug makers to accelerate drug discovery,... View more

Published Date : 30 Apr, 2026

Artificial Intelligence (AI) in healthcare is transforming medical imaging with the use of deep learning algorithms. One such application is the use of AI in ultrasound imaging. Ultrasound imaging is a commonly used imaging technique due to its non-invasive and cost-e... View more

Published Date : 30 Apr, 2026

Global intravenous (IV) ibuprofen market is estimated to be valued at USD 7.96 Bn in 2026 and is expected to exhibit a CAGR of 7% during the forecast period (2026 - 2033). Intravenous (IV) ibuprofen is used for pain relief and fever reduction for several decades. As... View more

Published Date : 30 Apr, 2026

The global gastric motility disorder drug market is estimated to be valued at USD 64.41 Bn in 2026 and is expected to exhibit a CAGR of 5.8% during the forecast period (2026 - 2033). Gastric motility disorder refers to conditions wherein the stomach takes more or le... View more

Published Date : 30 Apr, 2026

Global non opioid pain treatment market is estimated to be valued at USD 93.57  billion in 2026 and is expected to reach USD 171.04 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.0% from 2026 to 2033. Ri... View more

Published Date : 30 Apr, 2026

The medical second opinion market is estimated to be valued at USD 9.69 Bn in 2026 and is expected to reach USD 28.55 Bn by 2033, growing at a compound annual growth rate (CAGR) of 16.7% from 2026 to 2033. The global medical se... View more

Published Date : 30 Apr, 2026

Global cosentyx drug market is estimated to be valued at USD 6.16 Bn in 2026, and is expected to reach USD 10.35 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.7% from 2026 to 2033. Cosentyx (secukinumab) is a... View more

Published Date : 30 Apr, 2026

The Lenalidomide Drug Market is estimated to be valued at USD 15.04 Bn in 2026 and is expected to reach USD 23.83 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033. Lenalidomideis an immunomo... View more